#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Deafness Penile squamous cell carcinoma Fontan procedure Glomerulonephritis rapidly progressive Hypochondroplasia Congenital hypotransferrinaemia Breast cancer metastatic Hypochromic anaemia Pseudomyxoma peritonei Juvenile psoriatic arthritis Arterial disorder Chondrodystrophy Paraneoplastic neurological syndrome Ovarian cancer Uterine leiomyosarcoma More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Life with Disease Paraneoplastic neurological syndrome – Basic Information Retinoblastoma – Basic Information Cystic fibrosis lung – Basic Information Carcinoid syndrome – Life with Disease Systemic sclerosis pulmonary – Basic Information Hairy cell leukaemia recurrent – Life with Disease Ornithine transcarbamoylase deficiency – Trials in Disease Kearns-Sayre syndrome – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lib-01 Monohydrate IDOR-1117-2520C Glutenin Methotrexate Sodium Ponesimod Flucloxacillin Inavolisib Lebrikizumab MAGNESIUM CARBONATE HEAVY Pazopanib Cefepime ZINC GLUCONATE Prx005 Mercaptamine Clindamycin Phosphate LUNRESERTIB Dalbavancin Cetuximab GOLD SODIUM THIOSULFATE Methoxyflurane More therapies…

    Learn about Your Condition

    Cutaneous T-cell lymphoma Ventricular fibrillation Sinusitis bacterial SAPHO syndrome Cerebrovascular accident Anal incontinence Phenylketonuria Hysterectomy Primary hyperaldosteronism Hypotransferrinaemia Respiratory distress Developmental hip dysplasia Peptostreptococcus infection Lymphocytic leukaemia Essential thrombocythaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatic cirrhosis

  • Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Zibotentan
    • Dapagliflozin
    Belgium Czechia Germany Italy Poland Slovakia

  • Study on Belapectin for Preventing Esophageal Varices in Patients with NASH Cirrhosis

    Not recruiting

    4 1
    Investigated Diseases:
    • Varices oesophageal
    • Hepatic cirrhosis
    Investigated Drugs:
    • Galactoarabino-Rhamnogalacturonate
    Belgium France Germany Poland Spain

  • Study on the Effectiveness and Safety of Hepatitis B Surface Antigen and Imiquimod in Cirrhotic Patients Unresponsive to Conventional Vaccination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Hepatitis B Surface Antigen
    • Imiquimod
    France

  • Study on the Safety of Human Serum Albumin and Enoxaparin in Patients with Decompensated Cirrhosis at High Risk of Poor Outcome

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    • Enoxaparin Sodium
    France Germany Italy Spain

  • Long-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute hepatic failure
    • Inborn error of metabolism
    • Urea cycle disorder
    Investigated Drugs:
    • Hhalpc
    Belgium Bulgaria France Poland Spain

  • Study on Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis and Portal Hypertension

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Zibotentan
    • Dapagliflozin
    Austria Belgium Czechia Denmark France Germany +3
Previous Page
1 2 3 4

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!